Your browser doesn't support javascript.
loading
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.
Vermeire, Séverine; O'Byrne, Sharon; Keir, Mary; Williams, Marna; Lu, Timothy T; Mansfield, John C; Lamb, Christopher A; Feagan, Brian G; Panes, Julian; Salas, Azucena; Baumgart, Daniel C; Schreiber, Stefan; Dotan, Iris; Sandborn, William J; Tew, Gaik W; Luca, Diana; Tang, Meina T; Diehl, Lauri; Eastham-Anderson, Jeffrey; De Hertogh, Gert; Perrier, Clementine; Egen, Jackson G; Kirby, John A; van Assche, Gert; Rutgeerts, Paul.
Afiliación
  • Vermeire S; University of Leuven, Leuven, Belgium. Electronic address: severine.vermeire@uzleuven.be.
  • O'Byrne S; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Keir M; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Williams M; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Lu TT; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Mansfield JC; University of Newcastle, Newcastle upon Tyne, UK.
  • Lamb CA; University of Newcastle, Newcastle upon Tyne, UK.
  • Feagan BG; University of Western Ontario, London, ON, Canada.
  • Panes J; Hospital Clinic de Barcelona, Barcelona, Spain.
  • Salas A; Hospital Clinic de Barcelona, Barcelona, Spain.
  • Baumgart DC; Charité Medical School, Humboldt-University of Berlin, Berlin, Germany.
  • Schreiber S; Christian Albrechts University, Kiel, Germany.
  • Dotan I; Tel Aviv Medical Centre, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Sandborn WJ; University of California San Diego, La Jolla, CA, USA.
  • Tew GW; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Luca D; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Tang MT; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Diehl L; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Eastham-Anderson J; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • De Hertogh G; University of Leuven, Leuven, Belgium.
  • Perrier C; University of Leuven, Leuven, Belgium.
  • Egen JG; Research and Early Development, Genentech, South San Francisco, CA, USA.
  • Kirby JA; University of Newcastle, Newcastle upon Tyne, UK.
  • van Assche G; University of Leuven, Leuven, Belgium; University of Toronto, Toronto, ON, Canada.
  • Rutgeerts P; University of Leuven, Leuven, Belgium.
Lancet ; 384(9940): 309-18, 2014 Jul 26.
Article en En | MEDLINE | ID: mdl-24814090
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Año: 2014 Tipo del documento: Article